YIH
FBIO icon

Y-Intercept (HK)’s Fortress Biotech FBIO Stock Holding History

Y-Intercept (HK)’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,891
Closed -$24K – 1067
2022
Q2 		$24K Buy
+1,891
New +$28K ﹤0.01% 783

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Y-Intercept (HK)'s FBIO Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Fortress Biotech (FBIO) in Q3 2022, closing a stake of 1,891 shares — an estimated $24K sold.

Y-Intercept (HK) first reported a position in FBIO in Q2 2022 and held it in 1 quarter. The position peaked at $24K in Q2 2022. 64 funds tracked by Wall St. Rank hold FBIO as of Q3 2022.

  • Y-Intercept (HK) reported no remaining Fortress Biotech position as of Q3 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 1,891 Fortress Biotech shares in Q3 2022, an estimated $24K.
  • Y-Intercept (HK) first reported a position in Fortress Biotech in Q2 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s Fortress Biotech position peaked at $24K in Q2 2022.
  • 64 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.